[Debate on antiplatelet monotherapy: P2Y12 inhibitor monotherapy in patients with coronary artery disease]

G Ital Cardiol (Rome). 2023 Apr;24(4 Suppl 2):19S-20S. doi: 10.1714/4035.40101.

[Article in Italian]

Authors

Felice Gragnano¹, Marco Valgimigli², Paolo Calabrò¹

Affiliations

¹ Dipartimento di Scienze Mediche Traslazionali, Università degli Studi della Campania Luigi Vanvitelli, Caserta - Divisione di Cardiologia, Dipartimento Cardio-Vascolare, AORN Sant'Anna e San Sebastiano, Caserta.
² Istituto CardioCentro Ticino e Università della Svizzera Italiana (USI), Lugano, Svizzera.

PMID: 37158027
DOI: 10.1714/4035.40101

No abstract available

MeSH terms

Aspirin
Coronary Artery Disease* / drug therapy
Drug Therapy, Combination
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use
Purinergic P2Y Receptor Antagonists / therapeutic use

Substances

Platelet Aggregation Inhibitors
Aspirin
Purinergic P2Y Receptor Antagonists